AAPL $338.32 -1.96% ▼ ACN $260.94 +1.14% ▲ ADBE $251.47 +0.75% ▲ ADEA $20.67 -1.96% ▼ ADIG $18.68 +6.86% ▲ ADP $298.78 +1.68% ▲ ADSK $257.91 +3.33% ▲ AEHR $51.47 -6.60% ▼ AEVA $8.60 -7.31% ▼ AGYS $117.98 +1.88% ▲ AI $11.55 -2.37% ▼ AIP $17.85 -5.41% ▼ ALAB $229.67 -11.67% ▼ ALKT $13.34 +7.58% ▲ ALNT $84.17 -1.66% ▼ AMBA $61.67 -1.33% ▼ AMBQ $43.31 -10.63% ▼ AMD $466.84 -8.14% ▼ AMPL $16.79 -3.12% ▼ AMZN $245.63 +2.01% ▲ ANET $164.14 -3.34% ▼ AOSL $21.25 -7.49% ▼ APLD $16.22 -10.06% ▼ APP $228.85 +0.04% ▲ APPN $48.75 -0.51% ▼ APPS $8.46 -5.74% ▼ ARM $196.79 -4.88% ▼ ARRY $3.80 +11.11% ▲ ARW $203.21 -2.46% ▼ ASML $1,526.14 -2.94% ▼ AAPL $338.32 -1.96% ▼ ACN $260.94 +1.14% ▲ ADBE $251.47 +0.75% ▲ ADEA $20.67 -1.96% ▼ ADIG $18.68 +6.86% ▲ ADP $298.78 +1.68% ▲ ADSK $257.91 +3.33% ▲ AEHR $51.47 -6.60% ▼ AEVA $8.60 -7.31% ▼ AGYS $117.98 +1.88% ▲ AI $11.55 -2.37% ▼ AIP $17.85 -5.41% ▼ ALAB $229.67 -11.67% ▼ ALKT $13.34 +7.58% ▲ ALNT $84.17 -1.66% ▼ AMBA $61.67 -1.33% ▼ AMBQ $43.31 -10.63% ▼ AMD $466.84 -8.14% ▼ AMPL $16.79 -3.12% ▼ AMZN $245.63 +2.01% ▲ ANET $164.14 -3.34% ▼ AOSL $21.25 -7.49% ▼ APLD $16.22 -10.06% ▼ APP $228.85 +0.04% ▲ APPN $48.75 -0.51% ▼ APPS $8.46 -5.74% ▼ ARM $196.79 -4.88% ▼ ARRY $3.80 +11.11% ▲ ARW $203.21 -2.46% ▼ ASML $1,526.14 -2.94% ▼
Other NGM

CRISPR Therapeutics AG (CRSP)

Other · Healthcare · Biotechnology

CRSP
49.99-1.43 -2.78%Past year
Loading chart…
Loading financials…

Company snapshot

Ticker
CRSP
Exchange
NGM
Sector
Healthcare
Industry
Biotechnology
Market cap
$4.83B
Currency
USD
Website
https://www.crisprtx.com

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range…

Related Other stocks

Quotes & data — follow CRISPR Therapeutics AG (CRSP) across major market-data sources